Gadolinium-based contrast agents for magnetic resonance cancer imaging

Authors

Errata

This article corrects:

  1. Gadolinium-based contrast agents for magnetic resonance cancer imaging Volume 5, Issue 1, 1–18, Article first published online: 9 October 2012

In the recently published article cited above, an error was found in Figure 2. The correct figure is published below.

Figure 2.

Structures of the Gd(III)-based MRI contrast agents currently used in the clinical practice.

Ancillary